CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.49
arrow_downward
-1.32%(-0.10) 1D
Nov 17, 10:16:11 AM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.46
High
A$7.51
Low
A$7.36
Mkt. cap
377.64M
Avg. vol.
158.10K
Volume
7.20K
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.21
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.46
High
A$7.51
Low
A$7.36
Mkt. cap
377.64M
Avg. vol.
158.10K
Volume
7.20K
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.21
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
Bloomberg.com
·
1 hour ago
Wells Fargo Sees S&P 500 at 8,200 By End of 2027 as Profits Slow
RealMoney Pro
·
57 minutes ago
AI Stocks Drag the S&P 500 Back Toward the November 5th Lows
Investing.com
·
2 hours ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
Traders Union
·
43 minutes ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com